Matches in Nanopublications for { ?s ?p "[To better understand pathogenesis of ATL, we developed a novel xenogeneic engraftment model in which primary ATL cells are intravenously transplanted into neonatal nonobese diabetic (NOD)/severe-combined immunodeficiency (SCID)/beta2-microglobulin(null) (NOD/SCID/beta2m(null)) mice.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 11 of
11
with 100 items per page.
- NP391578.RAFKWEpCUbNHKCgJBZZWWwmzw072kKNMSyWn07q123sxc130_assertion description "[To better understand pathogenesis of ATL, we developed a novel xenogeneic engraftment model in which primary ATL cells are intravenously transplanted into neonatal nonobese diabetic (NOD)/severe-combined immunodeficiency (SCID)/beta2-microglobulin(null) (NOD/SCID/beta2m(null)) mice.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP391578.RAFKWEpCUbNHKCgJBZZWWwmzw072kKNMSyWn07q123sxc130_provenance.
- NP775666.RA5W-N0qFQwZtYFXvrI-FAQMRbKZPVdp3mP6ctOJm_C3g130_assertion description "[To better understand pathogenesis of ATL, we developed a novel xenogeneic engraftment model in which primary ATL cells are intravenously transplanted into neonatal nonobese diabetic (NOD)/severe-combined immunodeficiency (SCID)/beta2-microglobulin(null) (NOD/SCID/beta2m(null)) mice.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP775666.RA5W-N0qFQwZtYFXvrI-FAQMRbKZPVdp3mP6ctOJm_C3g130_provenance.
- NP494129.RAWrnBJ4f4Y66-g-ESiccrYM48C4wpKF2Ov2Tvv94QMnw130_assertion description "[To better understand pathogenesis of ATL, we developed a novel xenogeneic engraftment model in which primary ATL cells are intravenously transplanted into neonatal nonobese diabetic (NOD)/severe-combined immunodeficiency (SCID)/beta2-microglobulin(null) (NOD/SCID/beta2m(null)) mice.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP494129.RAWrnBJ4f4Y66-g-ESiccrYM48C4wpKF2Ov2Tvv94QMnw130_provenance.
- NP500245.RAKxJF4ovOzCZVgXLOrkVwDAyFncs3SHyJbettxVOfXS0130_assertion description "[To better understand pathogenesis of ATL, we developed a novel xenogeneic engraftment model in which primary ATL cells are intravenously transplanted into neonatal nonobese diabetic (NOD)/severe-combined immunodeficiency (SCID)/beta2-microglobulin(null) (NOD/SCID/beta2m(null)) mice.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP500245.RAKxJF4ovOzCZVgXLOrkVwDAyFncs3SHyJbettxVOfXS0130_provenance.
- assertion description "[To better understand pathogenesis of ATL, we developed a novel xenogeneic engraftment model in which primary ATL cells are intravenously transplanted into neonatal nonobese diabetic (NOD)/severe-combined immunodeficiency (SCID)/beta2-microglobulin(null) (NOD/SCID/beta2m(null)) mice.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[To better understand pathogenesis of ATL, we developed a novel xenogeneic engraftment model in which primary ATL cells are intravenously transplanted into neonatal nonobese diabetic (NOD)/severe-combined immunodeficiency (SCID)/beta2-microglobulin(null) (NOD/SCID/beta2m(null)) mice.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[To better understand pathogenesis of ATL, we developed a novel xenogeneic engraftment model in which primary ATL cells are intravenously transplanted into neonatal nonobese diabetic (NOD)/severe-combined immunodeficiency (SCID)/beta2-microglobulin(null) (NOD/SCID/beta2m(null)) mice.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP499854.RAYuziDMZ8rv3I1j3NHYbB9ySYh9h6h2qpoTQt98eyAXY130_assertion description "[To better understand pathogenesis of ATL, we developed a novel xenogeneic engraftment model in which primary ATL cells are intravenously transplanted into neonatal nonobese diabetic (NOD)/severe-combined immunodeficiency (SCID)/beta2-microglobulin(null) (NOD/SCID/beta2m(null)) mice.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP499854.RAYuziDMZ8rv3I1j3NHYbB9ySYh9h6h2qpoTQt98eyAXY130_provenance.
- NP494132.RAhilnUKyFAQEVnDCBJcH0Oc-fo2PqLxTeKGaJdCfG-t0130_assertion description "[To better understand pathogenesis of ATL, we developed a novel xenogeneic engraftment model in which primary ATL cells are intravenously transplanted into neonatal nonobese diabetic (NOD)/severe-combined immunodeficiency (SCID)/beta2-microglobulin(null) (NOD/SCID/beta2m(null)) mice.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP494132.RAhilnUKyFAQEVnDCBJcH0Oc-fo2PqLxTeKGaJdCfG-t0130_provenance.
- NP499855.RAoB-w_d1q8xAlcdf6EG2decAG3YW39gXqj9nBYiyGFPc130_assertion description "[To better understand pathogenesis of ATL, we developed a novel xenogeneic engraftment model in which primary ATL cells are intravenously transplanted into neonatal nonobese diabetic (NOD)/severe-combined immunodeficiency (SCID)/beta2-microglobulin(null) (NOD/SCID/beta2m(null)) mice.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP499855.RAoB-w_d1q8xAlcdf6EG2decAG3YW39gXqj9nBYiyGFPc130_provenance.
- NP499853.RAIU6XCQNQYyBOPif3iMxALlt-wctt57gJx1-otSjcGag130_assertion description "[To better understand pathogenesis of ATL, we developed a novel xenogeneic engraftment model in which primary ATL cells are intravenously transplanted into neonatal nonobese diabetic (NOD)/severe-combined immunodeficiency (SCID)/beta2-microglobulin(null) (NOD/SCID/beta2m(null)) mice.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP499853.RAIU6XCQNQYyBOPif3iMxALlt-wctt57gJx1-otSjcGag130_provenance.